⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
LEGN News
Legend Biotech Corporation American Depositary Shares
Legend Biotech to Present CARVYKTI® Data at 2026 Tandem Meetings Reinforcing Growing Evidence Supporting Earlier Use
globenewswire.com
LEGN
Legend Biotech Highlights Recent Business Updates at 44th Annual J.P. Morgan Healthcare Conference
globenewswire.com
LEGN
Legend Biotech to Present at the 44th Annual J.P. Morgan Healthcare Conference
globenewswire.com
LEGN
Legend Biotech Highlights New CARVYKTI® Data in Multiple Myeloma and First-in-Human Results from Novel CAR-T Platform in Non-Hodgkin Lymphoma at ASH 2025
globenewswire.com
LEGN
Legend Biotech Awarded 2025 FIBA Foreign Investor of the Year by Flanders Investment & Trade
globenewswire.com
LEGN
Legend Biotech Celebrates Official Opening of New State-of-the-Art Cell Therapy Research and Development Facility in Philadelphia
globenewswire.com
LEGN
Legend Biotech Reports Third Quarter 2025 Results and Recent Highlights
globenewswire.com
LEGN
Legend Biotech Announces 10 Presentations at the 67th American Society of Hematology (ASH) Annual Meeting
globenewswire.com
LEGN
Legend Biotech to Host Investor Conference Call on Third Quarter 2025 Results
globenewswire.com
LEGN